Using a two-degree polynomial regression analysis on UMSARS and disease duration to model MSA progression (r2 = 0.20), we show that plasma NfL concentrations increased slowly initially, then accelerated with the progression of motor impairment, followed by a deceleration later in the disease (Fig. 3A). The gene discussed is NEFL; the disease is multiple system atrophy.